Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Denosumab for the treatment of osteoporosis

McClung MR

Denosumab, a specific inhibitor of RANK ligand, is a novel therapy for postmenopausal osteoporosis and related disorders. An extensive clinical development program has evaluated the clinical efficacy and safety of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter to the Editor

Park YK

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Osteoporosis prevention and osteoporosis exercise in community-based public health programs

Nguyen VH

Osteoporosis is a serious public health concern worldwide, and community-based public health programs that increase osteoporosis preventive behaviors are ideal to combat this major public health issue. A review of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Response to the Editor

Ohta H, Uenishi K, Shiraki M

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Favorable effects of skeletal muscle on bone are distinguished according to gender and skeletal sites

Kim KM, Lee EY, Lim S, Jang HC, Kim CO

OBJECTIVES: The aim of this study was to investigate associations between skeletal muscle mass and bone mineral density according to gender and skeletal sites. METHODS: Using the data from Korean National...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study

Tanaka M, Nakamura Y, Itoh S, Kato Y

OBJECTIVES: This is an open labeled and retrospective cohort study which compared the effectiveness and safety of ibandronate (IBN) and minodronate (MIN) combined with eldecalcitol (ELD) in primary osteoporosis of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An update of the Malaysian Clinical Guidance on the management of glucocorticoid-induced osteoporosis, 2015

Yeap SS, Hew FL, Damodaran , Chee W, Lee JK, Goh EM, Chan SP, The Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis, 2015

OBJECTIVES: This Clinical Guidance is aimed to help practitioners assess, diagnose and manage their patients with glucocorticoid-induced osteoporosis (GIO), using the best available evidence. METHODS: A literature search using PubMed (MEDLINE)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change

Nakatoh S

OBJECTIVES: This study aimed to investigate the correlation between bone mineral density (BMD) and the turnover rate [√(MoMf²+ MoMr²), multiple of median formation (MoMf) was calculated as bone-specific alkaline phosphatase...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Associations between serum 25-hydroxyvitamin D3 level and skeletal muscle mass and lower limb muscle strength in Japanese middle-aged subjects

Kuwabara A, Tsugawa N, Kondo H, Ao M, Fujiwara H, Hosokawa N, Matsumoto , Tanaka K, Nakano T

OBJECTIVES: One of the important risk factors of falling is decreased muscle mass and muscle strength. Recently, there has been an increasing concern on the role of vitamin D in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr